Fluorescein angiographic findings in cases with intermediate uveitis in the inactive phase

Basit Öğe Kaydı
dc.authoridEsgin, Haluk/0000-0002-6611-6132
dc.authorwosidEsgin, Haluk/H-6460-2013
dc.contributor.authorGurlu, Vuslat Pelitli
dc.contributor.authorAlimgil, Murat Levent
dc.contributor.authorEsgin, Haluk
dc.date.accessioned2024-06-12T11:02:21Z
dc.date.available2024-06-12T11:02:21Z
dc.date.issued2007
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground: To determine fundus fluorescein angiography (FA) findings in cases with intermediate uveitis in the inactive phase. Methods: This prospective study included all eligible cases with a diagnosis of intermediate uveitis that were treated at the uvea unit of Trakya University ophthalmology department between January 2002 and January 2004. Study criteria included patients in the inactive phase who had no complaints, no biomicroscopic or ophthalmoscopic inflammatory findings in the anterior and posterior segments, and no period of inflammation that had occurred within the previous 6 months. Cases receiving immunosuppressive treatment were not excluded. FA was performed in all cases, which were evaluated by 2 independent observers. Results: A total of 21 eyes from 21 cases with intermediate uveitis were included in the study. FAs of the cases were taken approximately 8.8 (SD 5.4) months (range 6-23 months) after the last activation. In these FAs, no pathological findings were identified in 5 eyes (23.8%); optic disc hyperfluorescence was observed in 14 eyes (66.7%); large vein staining was observed in 2 eyes (9.5%); peripheral venous leakage was observed in 6 eyes (28.6%); and cystoid macular edema was observed in 5 eyes (23.8%). Interpretation: These findings indicate that retinal vascular inflammatory changes persist in cases with intermediate uveitis even if the clinical manifestations have been treated.en_US
dc.identifier.doi10.3129/can.j.ophthalmol.06-097
dc.identifier.endpage109en_US
dc.identifier.issn0008-4182
dc.identifier.issn1715-3360
dc.identifier.issue1en_US
dc.identifier.pmid17361250en_US
dc.identifier.scopus2-s2.0-33947161053en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage107en_US
dc.identifier.urihttps://doi.org/10.3129/can.j.ophthalmol.06-097
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21250
dc.identifier.volume42en_US
dc.identifier.wosWOS:000245794000018en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherCanadian Ophthal Socen_US
dc.relation.ispartofCanadian Journal Of Ophthalmology-Journal Canadien D Ophtalmologieen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFundus Fluorescein Angiographyen_US
dc.subjectIntermediate Uveitisen_US
dc.subjectRetinal Vasculitisen_US
dc.titleFluorescein angiographic findings in cases with intermediate uveitis in the inactive phaseen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu